欢迎来到《四川大学学报(医学版)》
张文, 黄鹤, 姜波, 等. 碘普罗胺诱发脑病1例报告[J]. 四川大学学报(医学版), 2021, 52(3): 528-530. DOI: 10.12182/20210560508
引用本文: 张文, 黄鹤, 姜波, 等. 碘普罗胺诱发脑病1例报告[J]. 四川大学学报(医学版), 2021, 52(3): 528-530. DOI: 10.12182/20210560508
ZHANG Wen, HUANG He, JIANG Bo, et al. Iopromide-Induced Encephalopathy: A Case Report and Literature Review[J]. Journal of Sichuan University (Medical Sciences), 2021, 52(3): 528-530. DOI: 10.12182/20210560508
Citation: ZHANG Wen, HUANG He, JIANG Bo, et al. Iopromide-Induced Encephalopathy: A Case Report and Literature Review[J]. Journal of Sichuan University (Medical Sciences), 2021, 52(3): 528-530. DOI: 10.12182/20210560508

碘普罗胺诱发脑病1例报告

Iopromide-Induced Encephalopathy: A Case Report and Literature Review

  • 摘要: 患者,男,42岁,因“发作性晕厥10+个月,胸闷20+ d,胸痛10+ d”入院。诊断为肥厚型心肌病,既往无高血压、糖尿病病史。为了解左室流出道压差及冠脉情况,予以左室心导管检查及冠脉造影术,心导管经右侧桡动脉入路,共使用碘质量浓度为370 mg I/mL的碘普罗胺200 mL,术后患者出现以剧烈头痛、皮质盲、神经精神症状为主要临床表现的造影剂脑病。予以降颅压、镇静及止痛等对症支持治疗,患者自愈。

     

    Abstract: A 42-year-old male was admitted for paroxysmal syncope for 10+ months, chest tightness for 20+ days and chest pain for 10+ days. The patient was diagnosed with hypertrophic cardiomyopathy. The patient did not have a history of hypertension or diabetes. Coronary angiography and left ventricular cardiac catheterization were done in order to examine the coronary artery and the pressure gradient of the left ventricular outflow tract. The cardiac catheterization was performed via a right radial artery approach and a total of 200 mL of 370 mg I/mL iopromide was injected. The patient developed contrast-induced encephalopathy following the cardiac catheterization procedure, displaying severe headache, cortical blindness and neuropsychiatric symptom as the main clinical manifestations. The patient was then given symptomatic and supportive treatment, including decreasing intracranial pressure, analgesics and sedatives, and the patient recovered.

     

© 2021 《四川大学学报(医学版)》编辑部 版权所有 cc

开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0

/

返回文章
返回